Cargando…
Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells
Reconstituted high density lipoprotein (rHDL) has been regarded as a promising brain-targeting vehicle for anti-glioma drugs under the mediation of apolipoprotein A-I (apoA-I). However, some stability issues relating to drug leakage and consequent reduced targeting efficiency in the course of discoi...
Autores principales: | Li, Jin, Han, Mengmeng, Li, Jianfei, Ge, Zhiming, Wang, Qianqian, Zhou, Kai, Yin, Xiaoxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170284/ https://www.ncbi.nlm.nih.gov/pubmed/32241173 http://dx.doi.org/10.1080/10717544.2020.1745330 |
Ejemplares similares
-
Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect
por: Han, Mengmeng, et al.
Publicado: (2020) -
Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022) -
Retardation of Aβ42 fibril formation by apolipoprotein A-I and recombinant HDL particles
por: Frankel, Rebecca, et al.
Publicado: (2023) -
Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020) -
Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I
por: Hossain, Mohammad A, et al.
Publicado: (2012)